专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US07282102B2 Method for manufacturing high silicon grain-oriented electrical steel sheet with superior core loss property 有权
标题翻译：具有优异的铁损性能的高硅晶粒取向电工钢板的制造方法
公开(公告)号：US07282102B2
公开(公告)日：2007-10-16
申请号：US10519521
申请日：2003-11-11
申请人： Kyu-Seung Choi , Jong-Soo Woo , Jae-Kwan Kim
发明人： Kyu-Seung Choi , Jong-Soo Woo , Jae-Kwan Kim
IPC分类号： H01F1/16
CPC分类号： C23C10/30 , C21D8/1244 , C21D8/1255 , C21D8/1277 , C23C10/02 , C23C10/20 , C23C10/44 , C23C10/46
摘要： A method for manufacturing a high silicon grain-oriented electrical steel sheet. In a method for manufacturing a high silicon grain-oriented electrical steel sheet, comprising the steps of: reheating and hot-rolling a steel slab to produce a hot-rolled steel sheet; annealing the hot-rolled sheet and cold rolling the annealed steel sheet so as to adjust a thickness of the steel sheet; decarburization annealing the cold rolled steel sheet; and finish-annealing the decarburization annealed steel sheet for secondary recrystallization, the improved method further comprising the step of: coating a powder coating agent for siliconization on a surface of the decarburization annealed steel sheet in a slurry state, the powder coating agent including 100 part by weight of MgO powder and 0.5-120 part by weight of sintered powder of Fe—Si compound containing 25-70 wt % Si sintered powder, the sintered powder having a grain size of −325 mesh; drying the resultant decarburization annealed steel sheet; and finish annealing the steel sheet under a conventional condition.
摘要翻译：一种高硅晶粒取向电工钢板的制造方法。在制造高硅晶粒取向电工钢板的方法中，包括以下步骤：对钢坯进行再加热和热轧以制造热轧钢板; 对该热轧板进行退火，对退火后的钢板进行冷轧，调整钢板的厚度; 冷轧钢板脱碳退火; 对用于二次再结晶的脱碳退火钢板进行最终退火，该改进方法还包括以下步骤：在浆料状态下在脱碳退火钢板的表面上涂覆硅化粉末涂料，所述粉末涂料包括100份的MgO粉末和0.5-120重量份含有25-70重量％Si烧结粉末的Fe-Si化合物的烧结粉末，烧结粉末的粒径为-325目; 干燥所得脱碳退火钢板; 并在常规条件下对钢板进行最终退火。

12. 发明申请

US20060078619A1 Method for the preparatin of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby 审中-公开
标题翻译：通过使用超临界流体法制备紫杉醇固体分散体的方法和由此制备的紫杉醇固体分散体
公开(公告)号：US20060078619A1
公开(公告)日：2006-04-13
申请号：US10534353
申请日：2003-11-13
申请人： Jong-Soo Woo , Hyuk-Jin Kim , Young-Hun Kim
发明人： Jong-Soo Woo , Hyuk-Jin Kim , Young-Hun Kim
IPC分类号： A61K9/14 , A61K31/337
CPC分类号： A61K9/5161 , A61K9/0019 , A61K9/1617 , A61K9/1641 , A61K9/1652 , A61K9/1694 , A61K9/5123 , A61K9/5146 , A61K9/5192 , A61K31/337
摘要： The present invention relates to a method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby, the paclitaxel solid dispersion being highly homogeneous and showing an improved solubility, thereby being effectively used for the preparation of paclitaxel injection and oral preparation having a high bioavailability.
摘要翻译：本发明涉及一种通过使用由此制备的超临界流体法和紫杉醇固体分散体制备紫杉醇固体分散体的方法，紫杉醇固体分散体是高度均匀的并且显示出改善的溶解度，从而有效地用于制备紫杉醇注射剂和具有高生物利用度的口服制剂。

13. 发明申请

US20050217762A1 Coating composition, and method for manufacturing high silicon electrical steel sheet using thereof 有权
标题翻译：涂料组合物及使用其制造高硅电工钢板的方法
公开(公告)号：US20050217762A1
公开(公告)日：2005-10-06
申请号：US10519227
申请日：2003-11-11
申请人： Kyu-Seung Choi , Jong-Soo Woo
发明人： Kyu-Seung Choi , Jong-Soo Woo
IPC分类号： C21D8/12 , C23C10/02 , C23C10/20 , C23C10/30 , H01F41/00
CPC分类号： C21D8/1277 , C21D8/1244 , C21D8/1266 , C23C10/02 , C23C10/20 , C23C10/30
摘要： There are provided a coating composition for siliconizing, and a method for manufacturing a high silicon electrical steel sheet using the same. The coating composition includes: a Fe—Si-based composite compound sintered powder having a grain size of −325 mesh and containing 20-70% silicon by weight; and a colloidal silica solution containing 15 -30 part by weight of silica solid matter with respect to 100 part by weight of the sintered powder.
摘要翻译：提供了用于硅化的涂料组合物，以及使用其的高硅电工钢板的制造方法。涂料组合物包括：粒径为-325目并含有20-70重量％硅的Fe-Si基复合化合物烧结粉末; 以及相对于烧结粉末100重量份含有15〜30重量份二氧化硅固体物质的胶体二氧化硅溶液。

14. 发明授权

US5958876A Cyclosporin-containing pharmaceutical compositions 失效
标题翻译：含环孢菌素的药物组合物
公开(公告)号：US5958876A
公开(公告)日：1999-09-28
申请号：US41456
申请日：1998-03-12
申请人： Jong Soo Woo
发明人： Jong Soo Woo
IPC分类号： A61K9/107 , A61K9/48 , A61K38/13 , A61K38/00
CPC分类号： A61K9/4858 , A61K38/13 , A61K9/1075
摘要： The present invention relates to a cyclosporin-containing soft capsule preparation which contains a composition containing cyclosporin as an active ingredient; a non-hydrophilic component propylene carbonate or a mixture of propylene carbonate and a hydrophilic component polyethylene glycol, one or a mixture of two or more selected from the group consisting of an esterified compound of fatty acid and primary alcohol, medium chain fatty acid triglyceride and fatty acid monoglyceride as an oil component; and a surfactant having an HLB (Hydrophilic Lipophilic Balance) value of 8 to 17.
摘要翻译：本发明涉及含有环孢菌素的软胶囊制剂，其含有含有环孢菌素作为活性成分的组合物; 非亲水性成分的碳酸亚丙酯或碳酸亚丙酯和亲水性成分聚乙二醇的混合物，选自脂肪酸和伯醇的酯化化合物，中链脂肪酸甘油三酸酯和中链脂肪酸甘油三酯中的一种或两种以上的混合物脂肪酸单甘油酯作为油成分; 和HLB（亲水亲油平衡）值为8〜17的表面活性剂。

15. 发明申请

US20140010872A1 ORAL COMPLEX COMPOSITION COMPRISING OMEGA-3 FATTY ACID ESTER AND HMG-COA REDUCTASE INHIBITOR 审中-公开
标题翻译：包含OMEGA-3脂肪酸酯和HMG-COA还原酶抑制剂的口服复合组合物
公开(公告)号：US20140010872A1
公开(公告)日：2014-01-09
申请号：US14006191
申请日：2012-03-23
申请人： Yong Il Kim , Eun Jin Yoon , Ho Taek Im , Yoon Sub Shin , Jae Hyun Park , Jong Soo Woo
发明人： Yong Il Kim , Eun Jin Yoon , Ho Taek Im , Yoon Sub Shin , Jae Hyun Park , Jong Soo Woo
IPC分类号： A61K9/48 , A61K31/505 , A61K31/23
CPC分类号： A61K31/23 , A61K9/4808 , A61K9/4891 , A61K31/202 , A61K31/505 , A61K2300/00
摘要： An oral complex composition comprising omega-3 fatty acid esters and HMG-CoA reductase inhibitor, can effectively raise serum HDL level while reducing serum LDL and TG levels and can be used to treat hyperlipidemia owing to its good drug dissolution rate and storage stability with showing no delayed release behavior even after 6 months of accelerated storage.
摘要翻译：包含ω-3脂肪酸酯和HMG-CoA还原酶抑制剂的口服复合物组合物可有效地提高血清HDL水平，同时降低血清LDL和TG水平，并且由于其具有良好的药物溶出速率和储存稳定性，可用于治疗高脂血症即使经过6个月的加速储存，也没有延迟释放行为。

16. 发明申请

US20130022684A1 ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT 审中-公开
标题翻译：含有抗坏血酸和碱性化合物的口服药物组合物
公开(公告)号：US20130022684A1
公开(公告)日：2013-01-24
申请号：US13637530
申请日：2011-04-12
申请人： Ki Young Jang , Mijin Park , Kyeong Soo Kim , Yong Il Kim , Jae Hyun Park , Jong Soo Woo
发明人： Ki Young Jang , Mijin Park , Kyeong Soo Kim , Yong Il Kim , Jae Hyun Park , Jong Soo Woo
IPC分类号： A61K9/14 , A61K9/20 , B29B9/12 , A61K31/192 , A61K9/00
CPC分类号： A61K9/1611 , A61K9/1617 , A61K9/1623 , A61K9/1652 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K31/192
摘要： An oral pharmaceutical composition of the present invention comprising fenofibric acid or a pharmaceutically acceptable salt thereof, and 0.22 to 1 part by weight of an alkalifying agent based on 1 part by weight of fenofibric acid has improved bioavailability and a minimized absorption deviation in the gastrointestinal tract, which is useful in treating hyperlipidemia and hypertriglyceridemia.
摘要翻译：包含非诺贝酸或其药学上可接受的盐的本发明的口服药物组合物和基于1重量份非诺贝酸的0.22至1重量份的碱化剂具有改善的生物利用度和最小化的胃肠道吸收偏差，其可用于治疗高脂血症和高甘油三酯血症。

17. 发明申请

US20120110957A1 METHOD FOR PREPARING RAPIDLY DISINTEGRATING FORMULATION FOR ORAL ADMINISTRATION 审中-公开
标题翻译：制备口服药物快速消毒配方的方法
公开(公告)号：US20120110957A1
公开(公告)日：2012-05-10
申请号：US13343879
申请日：2012-01-05
申请人： Chang Hyun LEE , Jong Soo Woo , Hong Gi Yi , Kyeong Soo Kim , Ho Taek Yim
发明人： Chang Hyun LEE , Jong Soo Woo , Hong Gi Yi , Kyeong Soo Kim , Ho Taek Yim
IPC分类号： B65B63/08
CPC分类号： A61K9/0056 , A61J3/10 , A61K9/2095 , B30B11/02 , B30B11/08 , B65B9/042 , B65B9/045
摘要： A method and packaging machine for preparing rapidly disintegrating formulations for oral administration are disclosed. The present invention is characterized in that a powdery mixture including a pharmaceutically active ingredient and a sugar or a sugar alcohol powder is filled into a packaging material and, thereafter, the mixture, filled in the packaging material, is heated. The present invention can simply and economically prepare an oral formulation which undergoes rapid disintegration in the oral cavity and provides for high-quality administration to patients.
摘要翻译：公开了用于制备用于口服给药的快速崩解制剂的方法和包装机。本发明的特征在于将包含药物活性成分和糖或糖醇粉末的粉末混合物填充到包装材料中，然后将填充在包装材料中的混合物加热。本发明可以简单且经济地制备在口腔中快速崩解并提供给患者高质量给药的口服制剂。

18. 发明申请

US20120044149A1 MISINPUT AVOIDANCE METHOD FOR MOBILE TERMINAL 审中-公开
标题翻译：移动终端的MISINPUT避免方法
公开(公告)号：US20120044149A1
公开(公告)日：2012-02-23
申请号：US13213926
申请日：2011-08-19
申请人： Dong Kyun Son , Dong Han Kang , Woo Chan Park , Jong Soo Woo , Sang Hoon Kang
发明人： Dong Kyun Son , Dong Han Kang , Woo Chan Park , Jong Soo Woo , Sang Hoon Kang
IPC分类号： G06F3/023
CPC分类号： G06F3/023
摘要： A misinput avoidance method of a mobile terminal may be implemented to prevent a misinput caused by contacting unintended keys around the target key. A misinput avoidance method of a mobile terminal according to the present invention includes detecting inputs of a plurality of keys and discriminating a target key from other keys. The method also includes extracting keys around the target key and registering the keys around the target keys as neighbor keys. The method further includes processing the input of the target key while blocking the inputs of the neighbor keys. The method further includes releasing, when the target key is released, the blocking of the inputs of the neighbor keys.
摘要翻译：可以实现移动终端的误输入回避方法，以防止由于围绕目标密钥接触意外的密钥造成的误输。根据本发明的移动终端的误输入回避方法包括检测多个密钥的输入并且将目标密钥与其他密钥相区别。该方法还包括提取围绕目标密钥的密钥并将目标密钥周围的密钥注册为相邻密钥。该方法还包括处理目标密钥的输入，同时阻挡相邻密钥的输入。该方法还包括当目标密钥被释放时释放邻居密钥的输入的阻塞。

19. 发明授权

US07704526B2 Sustained release composition for oral administration of drugs 失效
标题翻译：口服药物的缓释组合物
公开(公告)号：US07704526B2
公开(公告)日：2010-04-27
申请号：US10650931
申请日：2003-08-27
申请人： Jong-Soo Woo , Moon-Hyuk Chi
发明人： Jong-Soo Woo , Moon-Hyuk Chi
IPC分类号： A61K31/4422 , A61K31/351 , A61K9/22
CPC分类号： A61K9/2054 , A61K9/205
摘要： A sustained-release composition for oral administration of a drug, comprising the drug, a mixture of sodium alginate and xanthan gum as a carrier for sustained release and a mixture of hydroxypropyl methylcellulose and propylene glycol alginate as a gel hydration accelerator, which is capable of maintaining a constant drug level in blood for 24 hours or more. Due to rapid gel hydration without forming a non-gelated core, the drug release rate follows zero order kinetics and does not significantly vary with the degree of gastrointestinal motility.
摘要翻译：用于口服给药的缓释组合物，其包含药物，藻酸钠和黄原胶的混合物作为持续释放的载体，以及羟丙基甲基纤维素和海藻酸丙二醇酯作为凝胶水合促进剂的混合物，其能够维持血液中恒定的药物水平达24小时以上。由于快速凝胶水合而不形成非凝胶核，药物释放速率遵循零级动力学，并且随着胃肠蠕动程度而不显着变化。

20. 发明申请

US20080292702A1 Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same 审中-公开
标题翻译：具有低熔点的活性成分的固体分散体和包含其的口服给药片剂
公开(公告)号：US20080292702A1
公开(公告)日：2008-11-27
申请号：US12097299
申请日：2006-12-18
申请人： Jong Soo Woo , Sang Wook Kim , Hong Gi Yi , Jae Kuk Ryu
发明人： Jong Soo Woo , Sang Wook Kim , Hong Gi Yi , Jae Kuk Ryu
IPC分类号： A61K9/24 , A61K31/192 , A61K47/38 , A61K47/36 , A61K47/02 , A61K47/32 , A61K9/22
CPC分类号： A61K9/143 , A61K9/145 , A61K9/2054 , A61K9/209
摘要： A fused solid dispersion comprising an active ingredient having a melting point of 800 C or below and a pharmaceutically acceptable absorbent having a specific surface area ranging from 20 to 400 mVg can be conveniently compressed into a tablet without generating capping and sticking problems, and a tablet comprising said fused solid dispersion can maintain an uniform release rate over a prolonged time when orally administered.
摘要翻译：包含熔点为800℃以下的活性成分的熔融固体分散体和比表面积为20〜400m 2 / g的药学上可接受的吸收剂可以方便地压缩成片剂而不产生封盖和粘附问题，并将片剂包含所述熔融固体分散体在口服给药时可以在延长的时间内保持均匀的释放速率。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式